Electric Cardiometry-Guided Standard Versus Restricted Fluid Therapy In Robotic Prostaectomy
Recruiting
N/A
Interventional Study
Prostate Cancer
Surgery
Fluid Overload
Lactate Blood Increase
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 – 80
- Sex
- Male
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 90 (estimated)
- Sponsor
- Nazmy Edward Seif · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Fluid therapy during surgery is an important factor that is related to long term mortality and morbidity and it's directly related to tissue perfusion as well. The main target in any surgery is what is the optimum fluid therapy to maintain the tissue perfusion and the precise balance between hazardous effects of hypervolemia that may cause delayed wound healing due to surgical anastomosis disrupti…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male patient undergoing robotic assisted prostatectomy
* ASA I-III
Exclusion Criteria:
* ASA score more than III
* BMI more than 40
* Severe renal disease (GFR between 15 and 29)
* Previous renal surgery.
* Decompensated cardiac disease (NYHA class 3 or 4)
Contacts